Riitta Kaarteenaho
- Characterization of myofibroblasts cultured from small volumes of diagnostic bronchoalveolar lavage fluid samplesBy Riitta Kaarteenaho, Henna Karvonen, Terttu Harju, Raija Sormunen, Elisa Lappi-Blanco, Meeri Keinänen, Heta Merikallio and Siri LehtonenRiitta Kaarteenaho1Department of Medicine, Respiratory Research Unit, Oulu University Hospital, Oulu, FinlandHenna Karvonen1Department of Medicine, Respiratory Research Unit, Oulu University Hospital, Oulu, FinlandTerttu Harju1Department of Medicine, Respiratory Research Unit, Oulu University Hospital, Oulu, FinlandRaija Sormunen2Biocenter Oulu, University of Oulu, Oulu, FinlandElisa Lappi-Blanco3Department of Pathology, Oulu University Hospital, Oulu, FinlandMeeri Keinänen4Department of Anatomy and Cell Biology, Inst. of Biomedicine, University of Oulu, Oulu, FinlandHeta Merikallio1Department of Medicine, Respiratory Research Unit, Oulu University Hospital, Oulu, FinlandSiri Lehtonen4Department of Anatomy and Cell Biology, Inst. of Biomedicine, University of Oulu, Oulu, Finland
- Myofibroblast expression in airways and alveoli is affected by smoking and COPDBy Henna Karvonen, Siri Lehtonen, Terttu Harju, Raija Sormunen, Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson and Riitta KaarteenahoHenna Karvonen1Department of Internal Medicine, Institute of Clinical Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, FinlandSiri Lehtonen2Department of Anatomy and Cell Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, FinlandTerttu Harju1Department of Internal Medicine, Institute of Clinical Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, FinlandRaija Sormunen3Biocenter Oulu, University of Oulu, Oulu, Finland5Department of Pathology, Oulu University Hospital, Oulu, FinlandElisa Lappi-Blanco4Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland5Department of Pathology, Oulu University Hospital, Oulu, FinlandJohanna Mäkinen4Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland5Department of Pathology, Oulu University Hospital, Oulu, FinlandKirsi Laitakari1Department of Internal Medicine, Institute of Clinical Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, FinlandShirley Johnson1Department of Internal Medicine, Institute of Clinical Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, FinlandRiitta Kaarteenaho1Department of Internal Medicine, Institute of Clinical Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland7Clinical Research Center, Oulu University Hospital, Oulu, Finland6Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
- Pirfenidone and BIBF1120 regulate properties of myofibroblastsBy Siri Lehtonen, Henna Karvonen, Elisa Lappi-Blanco, Raija Sormunen, Ulrika Zagai, Magnus Sköld and Riitta KaarteenahoSiri Lehtonen1Dept. of Anatomy and Cell Biology, University of Oulu, Oulu, FinlandHenna Karvonen2Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland3Dept. of Internal Medicine/ Respiratory Research Unit, Institute of Clinical Medicine, University of Oulu, Oulu, FinlandElisa Lappi-Blanco4Dept. of Pathology, University of Oulu, Oulu, Finland5Dept. of Pathology, Oulu University Hospital, Oulu, FinlandRaija Sormunen4Dept. of Pathology, University of Oulu, Oulu, Finland5Dept. of Pathology, Oulu University Hospital, Oulu, Finland6Biocenter Oulu, University of Oulu, Oulu, FinlandUlrika Zagai7Dept. of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockhom, SwedenMagnus Sköld8Dept. of Medicine, Division of Respiratory Medicine, Karolinska University Hospital Solna, Stockholm, SwedenRiitta Kaarteenaho2Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland3Dept. of Internal Medicine/ Respiratory Research Unit, Institute of Clinical Medicine, University of Oulu, Oulu, Finland9Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland10Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland
- Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern FinlandBy Miia Kärkkäinen, Hannu-Pekka Kettunen, Hanna Nurmi, Minna Purokivi and Riitta KaarteenahoMiia Kärkkäinen1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland3Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, FinlandHannu-Pekka Kettunen2Department of Clinical Radiology, Kuopio University Hospital, Kuopio, FinlandHanna Nurmi1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland3Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, FinlandMinna Purokivi1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandRiitta Kaarteenaho1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland3Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland4Respiratory Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
- Do physicians in primary health care recognize pulmonary fibrosis?By Minna Purokivi, Marjukka Myllärniemi, Ulla Hodgson, Eija-Riitta Salomaa and Riitta KaarteenahoMinna Purokivi1Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandMarjukka Myllärniemi2Department of Clinical Medicine and Transplantation Laboratory, University of Helsinki, Helsinki, Finland3Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, FinlandUlla Hodgson2Department of Clinical Medicine and Transplantation Laboratory, University of Helsinki, Helsinki, Finland3Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, FinlandEija-Riitta Salomaa4Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, FinlandRiitta Kaarteenaho1Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland5Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland6Respiratory Research Unit and Clinical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland
- LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPDBy David Balgoma, Mingxing Yang, Marcus Sjodin, Stuart Snowden, Reza Karimi, Bettina Levanen, Heta Merikallio, Riitta Kaarteenaho, Lena Palmberg, Kjell Larsson, David Erle, Sven-Erik Dahlen, Barbro Dahlen, Magnus Skold, Asa Wheelock and Craig WheelockDavid Balgoma1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenMingxing Yang2Medicine, Karolinska Institute, Stockholm, SwedenMarcus Sjodin1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenStuart Snowden1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenReza Karimi2Medicine, Karolinska Institute, Stockholm, SwedenBettina Levanen2Medicine, Karolinska Institute, Stockholm, SwedenHeta Merikallio2Medicine, Karolinska Institute, Stockholm, SwedenRiitta Kaarteenaho3Respiratory Unit, Oulu University, Oulu, FinlandLena Palmberg4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenKjell Larsson4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenDavid Erle5Medicine, University of California San Francisco, San Francisco, United StatesSven-Erik Dahlen4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenBarbro Dahlen6Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, SwedenMagnus Skold2Medicine, Karolinska Institute, Stockholm, SwedenAsa Wheelock2Medicine, Karolinska Institute, Stockholm, SwedenCraig Wheelock1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
- Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinomaBy Siri Lehtonen, Henna Karvonen, Elisa Lappi-Blanco, Raija Sormunen and Riitta KaarteenahoSiri Lehtonen1Department of Anatomy and Cell Biology, University of Oulu, Oulu, Finland2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, FinlandHenna Karvonen2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, FinlandElisa Lappi-Blanco3Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, FinlandRaija Sormunen3Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland4Biocenter Oulu, University of Oulu, Oulu, FinlandRiitta Kaarteenaho2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland5Department of Internal Medicine, University of Oulu, Oulu, Finland6Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland7Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland
- Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung diseaseBy Hanna Nurmi, Miia Kärkkäinen, Riitta Kaarteenaho and Minna PurokiviHanna Nurmi1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland2Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, FinlandMiia Kärkkäinen1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland2Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, FinlandRiitta Kaarteenaho1Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland2Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland3Respiratory Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, FinlandMinna Purokivi2Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland
- MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinomaBy Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen and Riitta KaarteenahoElisa Lappi-Blanco1Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, FinlandJohanna Mäkinen2Medical Reserach Center Oulu, Oulu University Hospital and University of Oulu, Oulu, FinlandKirsi Laitakari3Medical Informatics and Statistics Research Group, University of Oulu, Oulu, FinlandShirley Johnson4Department of Anatomy and Cell Biology, University of Oulu, Oulu, FinlandRiitta Mäkitaro5Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland, Kuopio, FinlandRisto Bloigu6Center of Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandSiri Lehtonen1Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, FinlandTimo Väisänen2Medical Reserach Center Oulu, Oulu University Hospital and University of Oulu, Oulu, FinlandRiitta Kaarteenaho3Medical Informatics and Statistics Research Group, University of Oulu, Oulu, Finland
- Effect of nintedanib, pirfenidone, N-acetylcysteine and their combinations on cultured myofibroblast-type cells derived from patients with asbestosis and idiopathic pulmonary fibrosisBy Anniina Veijola, Riitta Kaarteenaho and Siri LehtonenAnniina Veijola1Department of Anatomy and Cell Biology, University of Oulu, Oulu, Finland2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, FinlandRiitta Kaarteenaho1Department of Anatomy and Cell Biology, University of Oulu, Oulu, Finland2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, FinlandSiri Lehtonen2Department of Medicine, Respiratory Research Unit and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland3Department of Internal Medicine / Respiratory Research Unit, University of Oulu, Oulu, Finland4Unit of Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland and Center for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland
- Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPDBy David Balgoma, Mingxing Yang, Marcus Sjödin, Stuart Snowden, Reza Karimi, Bettina Levänen, Heta Merikallio, Riitta Kaarteenaho, Lena Palmberg, Kjell Larsson, David J. Erle, Sven-Erik Dahlén, Barbro Dahlén, C. Magnus Sköld, Åsa M. Wheelock and Craig E. WheelockArticle | Published in 2016 in European Respiratory JournalDavid Balgoma1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenMingxing Yang3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenMarcus Sjödin1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenStuart Snowden1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenReza Karimi3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenBettina Levänen3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenHeta Merikallio3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden4Respiratory Unit, Medical Research Center Oulu, Oulu University/UniversityHospital, Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland & Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandRiitta Kaarteenaho4Respiratory Unit, Medical Research Center Oulu, Oulu University/UniversityHospital, Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland & Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandLena Palmberg5Lung and Airway Research Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenKjell Larsson5Lung and Airway Research Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenDavid J. Erle6Division of Pulmonary and Critical Care, Department of Medicine and Lung Biology Center, University of California San Francisco, San Francisco, USASven-Erik Dahlén2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenBarbro Dahlén7Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, SwedenC. Magnus Sköld3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenÅsa M. Wheelock3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden8Both authors contributed equallyCraig E. Wheelock1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden8Both authors contributed equally
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.